D-PHARMA
ActiveSummary
For D-PHARMA, one filing cycle of the annual accounts is missing. The 2024 annual accounts show equity of €285k and a net result of €34k. Equity is growing by ~6.5% per year across the filed fiscal years. Its solvency ranks better than 78% of 26043 sector peers (fiscal year 2024). The company has been active since 1995 and the Belgian State Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 1.2% (low).
Checked score
No current score
Figures too old
The available figures for FY 2024 are too old to assess current financial health.
Filing: One filing cycle is missing
Axes, FY 2024 · tick = 2023
Profitability79▼-3
Solvency92▼-4
Growth78=
Track record100
Bankruptcy probability, 12 months
1.2%
Low
0%0.5%1.5%4%10%≥ 25%
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
66.6%
Return on assets
8%
Age of the figures
30 mo
raises risk · Annual accounts not filed
The financial year that closed on 31-03-2025 was due at the National Bank by 31-10-2025. Nothing is on record, 330 days later.
NBB · 10 filingsPosition against the passed deadline
31-03-2025 close31-10-2025 deadline26-09-2026 today
neutral · Filed after the deadline
The financial year that closed on 31-03-2024 was due by 31-10-2024 and was filed on 28-11-2024, 28 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not filed
2024
28 d late
2023
30 d late
2022
60 d late
2021
29 d late
2020
13 d late
2019
32 d late
← before the deadline
after the deadline →
Checked, nothing found (1)
History
Go further with this company
How much credit can you give this customer, and on what term?Credit simulator What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed Roughly what is this company worth?Value indication
Financials · fiscal year 2024, micro schema
Equity
€285k▲ 3.4%
2023 · €276k
Total assets
€428k▲ 10.3%
2023 · €388k
Net result
€34k▼ 14.1%
2023 · €40k
Working capital
€308k▲ 3.5%
2023 · €298k
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Operating result€68k▲ 375%€22k▼ 68.4%€50k▲ 133%€48k▼ 4.5%€41k▼ 15.1%
Net result€52k▲ 776%€14k▼ 73.1%€43k▲ 204%€40k▼ 6.7%€34k▼ 14.1%
Equity€229k▲ 13.6%€243k▲ 6.2%€261k▲ 7.3%€276k▲ 5.7%€285k▲ 3.4%
Total assets€360k▲ 11.3%€350k▼ 2.8%€376k▲ 7.6%€388k▲ 3.1%€428k▲ 10.3%
Debt€106k▲ 9.6%€82k▼ 22.7%€90k▲ 10.5%€87k▼ 3.5%€118k▲ 35.1%
Working capital€254k▲ 12.1%€268k▲ 5.6%€285k▲ 6.4%€298k▲ 4.6%€308k▲ 3.5%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2024 is 15% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €428k
Fixed assets
€2k ▼ 41.6%
Current assets
€426k ▲ 10.6%
Equity and liabilities €428k
Equity
€285k ▲ 3.4%
Provisions
€25k =
Debt
€118k ▲ 35.1%
Debt's share of the balance-sheet total rises from 22.5% to 27.6%. Equity and debt are higher.
Key figures and ratios
EBITDA
€42k▼
2023 · €49k
Cash flow
€35k▼
2023 · €41k
Current ratio
3.61▼
2023 · 4.41
Quick ratio
3.49▼
2023 · 4.25
Debt to equity
0.41▲
2023 · 0.32
ROE
12.0%▼
2023 · 14.5%
ROA
8.0%▼
2023 · 10.3%
Interest coverage
14.42▼
2023 · 111.65
Debt ≤ 1 year
€118k▲
2023 · €87k
Income taxes
€4k▼
2023 · €8k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | - | - | €25 | €628 | €1k | ▲ 75.3% |
| Other operating charges640/8 | - | - | €854 | €528 | €6k | ▲ 1,070% |
| Gross operating margin9900 | €70k | €22k | €51k | €49k | €48k | ▼ 2.3% |
| Operating profit (loss)9901 | €68k | €22k | €50k | €48k | €41k | ▼ 15.1% |
| Financial income75/76B | - | - | €117 | €44 | - | - |
| Recurring financial income75 | €5 | - | €117 | €44 | - | - |
| Financial charges65/66B | - | - | €473 | €437 | €3k | ▲ 567% |
| Recurring financial charges65 | €3k | €2k | €473 | €437 | €3k | ▲ 567% |
| Profit (loss) for the period before taxes9903 | €66k | €20k | €50k | €48k | €38k | ▼ 20.5% |
| Income taxes67/77 | €14k | €6k | €7k | €8k | €4k | ▼ 52.6% |
| Profit (loss) for the period9904 | €52k | €14k | €43k | €40k | €34k | ▼ 14.1% |
| Profit (loss) for the period to be appropriated9905 | €52k | €14k | €43k | €40k | €34k | ▼ 14.1% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €360k | €350k | €376k | €388k | €428k | ▲ 10.3% |
| Fixed assets21/28 | - | - | €730 | €3k | €2k | ▼ 41.6% |
| Tangible fixed assets22/27 | - | - | €730 | €3k | €2k | ▼ 41.6% |
| Furniture and vehicles24 | - | - | €730 | €3k | €2k | ▼ 41.6% |
| Current assets29/58 | €360k | €350k | €375k | €385k | €426k | ▲ 10.6% |
| Stocks and contracts in progress3 | €14k | €15k | €13k | €14k | €15k | ▲ 6.4% |
| Stocks30/36 | - | - | €13k | €14k | €15k | ▲ 6.4% |
| Amounts receivable within one year40/41 | €305k | €312k | €344k | €357k | €375k | ▲ 5.1% |
| Trade receivables40 | - | - | €26k | €26k | €32k | ▲ 24.4% |
| Other amounts receivable41 | - | - | €318k | €331k | €343k | ▲ 3.6% |
| Cash at bank and in hand54/58 | €40k | €23k | €18k | €14k | €36k | ▲ 154% |
| Deferred charges and accrued income490/1 | - | - | €571 | €851 | €1k | ▲ 38.9% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €360k | €350k | €376k | €388k | €428k | ▲ 10.3% |
| Equity10/15 | €229k | €243k | €261k | €276k | €285k | ▲ 3.4% |
| Contributions10/11 | €19k | - | €19k | €19k | €19k | = |
| Reserves13 | €210k | €224k | €242k | €257k | €266k | ▲ 3.6% |
| Non-distributable reserves130/1 | - | - | €2k | €2k | €2k | = |
| Reserves not available under the articles1311 | - | - | €2k | €2k | €2k | = |
| Distributable reserves133 | - | - | €240k | €255k | €264k | ▲ 3.6% |
| Provisions and deferred taxes16 | €25k | €25k | €25k | €25k | €25k | = |
| Provisions for liabilities and charges160/5 | - | - | €25k | €25k | €25k | = |
| Pensions and similar obligations160 | - | - | €25k | €25k | €25k | = |
| Amounts payable17/49 | €106k | €82k | €90k | €87k | €118k | ▲ 35.1% |
| Amounts payable within one year42/48 | €106k | €82k | €90k | €87k | €118k | ▲ 35.1% |
| Trade debts44 | €59k | €44k | €58k | €50k | €80k | ▲ 61.4% |
| Suppliers440/4 | - | - | €58k | €50k | €80k | ▲ 61.4% |
| Taxes, remuneration and social security45 | - | - | €6k | €8k | €8k | ▲ 0.9% |
| Taxes450/3 | - | - | €6k | €8k | €8k | ▲ 0.9% |
| Other amounts payable47/48 | - | - | €27k | €30k | €30k | ▲ 0.3% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €52k | €14k | €43k | €40k | €34k | ▼ 14.1% |
| + Depreciation and write-downs630 | - | - | €25 | €628 | €1k | ▲ 75.3% |
| Operating cash flow (approximation) | €52k | €14k | €43k | €41k | €35k | ▼ 12.8% |
| Investment in fixed assets (approximation) | - | - | - | €-3k | €1 | ▲ 100% |
| Change in cash | - | €-17k | €-5k | €-4k | €22k | ▲ 672% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2024
28-11
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 28 days late
2023
30-11
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2022
30-12
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 60 days late
2021
29-11
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 29 days late
2020
13-11
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 13 days late
31-03
Financial
Highest result since 2019net €52k ▲776%
Operating result €68k, net result €52k, both a record.
2019
02-12
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 32 days late
2018
30-11
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 30 days late
2017
30-11
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 30 days late
2016
28-11
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 28 days late
2015
30-11
NBB filing
Annual accounts filed
fiscal year 2015 · full schema · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Schaarbeek · 1 establishment unit since 1996
Ground area
687 m²
Building footprint
452 m²
Volume, LiDAR
6,872 m³
Parcel 21904B0510/00Z000, Brussels · tallest building 25.1 m, ±7 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
Jan Stobbaertslaan 10, 1030 Schaarbeek
since 19962.075.611.047
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21904B0510/00Z000 | Brussels | 686 m² | 1 · 452 m² | 25.1 m · 7 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteSchaarbeek2.075.611.047
Similar companies · same sector, comparable size
Pharmacie du Pont de l'Etat
BE 0443.813.503
Erquelinnes · Eq €284,941
PHARDEN
BE 0449.472.066
Bièvre · Eq €284,862
JD Farma
BE 0728.585.113
Zedelgem · Eq €284,990
MAXPHARMA
BE 0471.830.863
Etterbeek · Eq €284,725
Apotheek Colpaert
BE 0845.626.204
Harelbeke · Eq €285,141
Of 5,221 companies in sector 47730 we hold annual accounts for 3,860. 3,513 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded11-07-1995
Fiscal year end31-03
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Scores and ratios are computed by Checked and are not a credit decision.